Levin Capital Strategies, L.P. 23and Me Holding Co. Transaction History

Levin Capital Strategies, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.29 - $0.51 $166,750 - $293,250	575,000 Added 370.97%	730,000 $255,000
Q2 2024 Aug 07, 2024	BUY	$0.36 - $0.61 $55,800 - $94,550	155,000 New	155,000 $60,000
Q2 2022 Aug 15, 2022	SELL	$2.19 - $3.98 $10,950 - $19,900	-5,000 Reduced 23.26%	16,500 $41,000
Q1 2022 May 02, 2022	SELL	$3.28 - $7.12 $93,480 - $202,920	-28,500 Reduced 57.0%	21,500 $82,000
Q4 2021 Feb 15, 2022	BUY	$6.55 - $13.25 $327,500 - $662,500	50,000 New	50,000 $333,000

8.44M

50K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $712M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

Stay updated on Levin Capital Strategies, L.P. with notifications on news.